Quick Answer
ACHIEVE LIFE SCIENCES, INC. reported Cash and Equivalents of $20.93 million for fiscal year 2025.
ACHIEVE LIFE SCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $20.93M | +64.1% |
| 2024 | $12.75M | -18.0% |
| 2023 | $15.55M | -37.2% |
| 2022 | $24.77M | -42.4% |
| 2021 | $43.02M | +20.0% |
| 2020 | $35.85M | +115.2% |
| 2019 | $16.66M | +75.1% |
| 2018 | $9.52M | +80.1% |
| 2017 | $5.28M | +35126.7% |
| 2016 | $15.0K | -100.0% |
| 2015 | $34.31M | +23.0% |
| 2014 | $27.90M | +91.2% |
| 2013 | $14.59M | -19.3% |
| 2012 | $18.07M | -36.6% |
| 2011 | $28.52M | +21.2% |
| 2010 | $23.53M | -62.1% |
| 2009 | $62.05M | +714.5% |
| 2008 | $7.62M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.93M | +234.6% | -38.4% |
| June 30, 2025 | $51.87M | +251.5% | +298.5% |
| March 31, 2025 | $13.02M | -80.4% | +2.1% |
| December 31, 2024 | $12.75M | -18.0% | +33.6% |
| September 30, 2024 | $9.54M | -52.1% | -35.3% |
| June 30, 2024 | $14.76M | -41.1% | -77.8% |
| March 31, 2024 | $66.40M | +302.1% | +327.1% |
| December 31, 2023 | $15.55M | -37.2% | -22.0% |
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +64.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, ACHIEVE LIFE SCIENCES, INC.’s cash and equivalents has grown by 174.7% (from $7.62 million to $20.93 million).
- The most recent figure is from ACHIEVE LIFE SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: